New evidence clearly suggests an association between post-ischemic dementia and the ischemic neuropathological changes in the amyloid and the tau protein that are characteristic of Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.